Stockscreener 앱 받기
1.45
2.84%
0.04
전일 마감가:
$1.41
열려 있는:
$1.4
하루 거래량:
332.30K
Relative Volume:
0.44
시가총액:
$93.66M
수익:
$212.69M
순이익/손실:
$-59.00M
주가수익비율:
-1.553
EPS:
-0.9337
순현금흐름:
$-29.49M
1주 성능:
+13.28%
1개월 성능:
-12.65%
6개월 성능:
-76.84%
1년 성능:
-82.57%
1일 변동 폭
$1.315
$1.46
1주일 범위
$1.17
$1.46
52주 변동 폭
$1.17
$8.1299
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.45 | 93.66M | 212.69M | -59.00M | -29.49M | -0.9337 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
TMCI PE Ratio & Valuation, Is TMCI Overvalued - Intellectia AI
Treace Medical Concepts (TMCI) price target decreased by 10.94% to 3.63 - MSN
CFO at Treace Medical (TMCI) granted 100,000 performance stock units - stocktitan.net
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
TMCI Should I Buy - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - accessnewswire.com
Value Recap: How correlated is Treace Medical Concepts Inc to the S P5002026 AllTime Highs & Weekly High Return Stock Opportunities - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect | NDAQ:TMCI | Press Release - Stockhouse
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 earnings call transcript - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Quarterly Earnings: Is Treace Medical Concepts Inc gaining market shareWeekly Trading Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
CIBC Bancorp USA Inc. Acquires New Stake in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $4.77 Average PT from Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Treace Medical Concepts, Inc.Common Stock (NQ: TMCI - The Chronicle-Journal
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
How Treace Medical Concepts Inc. (TMCI) Affects Rotational Strategy Timing - Stock Traders Daily
Resistance Check: Is Treace Medical Concepts Inc gaining market shareMarket Trend Summary & Technical Buy Zone Confirmations - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical (TMCI) legal chief reports routine tax share withholding - Stock Titan
Treace Medical Concepts (TMCI) CFO has 4,659 shares withheld for taxes - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Treace Medical Concepts (TMCI) executive has 1,797 shares withheld for taxes - stocktitan.net
Market Catalysts: Why is Treace Medical Concepts Inc stock going up2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Treace Medical Concepts Hits New 52-Week Low at $1.58 - Markets Mojo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Given New $7.00 Price Target at Lake Street Capital - Defense World
Analysts Are Neutral on Top Healthcare Stocks: Amgen (AMGN), Treace Medical Concepts (TMCI) - The Globe and Mail
Treace Medical Concepts (NASDAQ:TMCI) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
TMCI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Treace Medical Earnings Call Balances Progress and Pressure - TipRanks
Lake Street Capital Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
Treace Medical Concepts Q4 Earnings Call Highlights - Defense World
Truist Securities Adjusts Treace Medical Concepts PT to $2 From $3, Maintains Hold Rating - marketscreener.com
Treace Medical net loss hits USD 9.4M in Q4 2025 - Medical Buyer
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Reveals Potential 100% Upside - DirectorsTalk Interviews
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Is Treace Medical Concepts Inc gaining market shareEarnings Growth Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Earnings call transcript: Treace Medical Concepts Q4 2025 reports revenue decline, stock edges up - Investing.com Canada
Treace Medical Concepts Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Treace Medical Concepts earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):